» Articles » PMID: 23935493

Prion Replication Occurs in Endogenous Adult Neural Stem Cells and Alters Their Neuronal Fate: Involvement of Endogenous Neural Stem Cells in Prion Diseases

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2013 Aug 13
PMID 23935493
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Prion diseases are irreversible progressive neurodegenerative diseases, leading to severe incapacity and death. They are characterized in the brain by prion amyloid deposits, vacuolisation, astrocytosis, neuronal degeneration, and by cognitive, behavioural and physical impairments. There is no treatment for these disorders and stem cell therapy therefore represents an interesting new approach. Gains could not only result from the cell transplantation, but also from the stimulation of endogenous neural stem cells (NSC) or by the combination of both approaches. However, the development of such strategies requires a detailed knowledge of the pathology, particularly concerning the status of the adult neurogenesis and endogenous NSC during the development of the disease. During the past decade, several studies have consistently shown that NSC reside in the adult mammalian central nervous system (CNS) and that adult neurogenesis occurs throughout the adulthood in the subventricular zone of the lateral ventricle or the Dentate Gyrus of the hippocampus. Adult NSC are believed to constitute a reservoir for neuronal replacement during normal cell turnover or after brain injury. However, the activation of this system does not fully compensate the neuronal loss that occurs during neurodegenerative diseases and could even contribute to the disease progression. We investigated here the status of these cells during the development of prion disorders. We were able to show that NSC accumulate and replicate prions. Importantly, this resulted in the alteration of their neuronal fate which then represents a new pathologic event that might underlie the rapid progression of the disease.

Citing Articles

Potential Therapeutic Use of Stem Cells for Prion Diseases.

Zayed M, Kook S, Jeong B Cells. 2023; 12(19).

PMID: 37830627 PMC: 10571911. DOI: 10.3390/cells12192413.


Differentiated cultures of an immortalized human neural progenitor cell line do not replicate prions despite PrP overexpression.

Slota J, Wang X, Lusansky D, Medina S, Booth S Prion. 2023; 17(1):116-132.

PMID: 37131335 PMC: 10158546. DOI: 10.1080/19336896.2023.2206315.


Dysregulation of neuroprotective astrocytes, a spectrum of microglial activation states, and altered hippocampal neurogenesis are revealed by single-cell RNA sequencing in prion disease.

Slota J, Sajesh B, Frost K, Medina S, Booth S Acta Neuropathol Commun. 2022; 10(1):161.

PMID: 36352465 PMC: 9647949. DOI: 10.1186/s40478-022-01450-4.


Impact of Oxidative DNA Damage and the Role of DNA Glycosylases in Neurological Dysfunction.

de Sousa M, Ye J, Luna L, Hildrestrand G, Bjoras K, Scheffler K Int J Mol Sci. 2021; 22(23).

PMID: 34884729 PMC: 8657561. DOI: 10.3390/ijms222312924.


Viral and Prion Infections Associated with Central Nervous System Syndromes in Brazil.

Sousa Jr I, Dos Santos F, de Paula V, Vieira T, Dias H, Barros C Viruses. 2021; 13(7).

PMID: 34372576 PMC: 8310075. DOI: 10.3390/v13071370.


References
1.
Rambold A, Muller V, Ron U, Ben-Tal N, Winklhofer K, Tatzelt J . Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J. 2008; 27(14):1974-84. PMC: 2486277. DOI: 10.1038/emboj.2008.122. View

2.
Mallucci G, Collinge J . Rational targeting for prion therapeutics. Nat Rev Neurosci. 2004; 6(1):23-34. DOI: 10.1038/nrn1584. View

3.
Crozet C, Flamant F, Bencsik A, Aubert D, Samarut J, Baron T . Efficient transmission of two different sheep scrapie isolates in transgenic mice expressing the ovine PrP gene. J Virol. 2001; 75(11):5328-34. PMC: 114937. DOI: 10.1128/JVI.75.11.5328-5334.2001. View

4.
Cayre M, Canoll P, Goldman J . Cell migration in the normal and pathological postnatal mammalian brain. Prog Neurobiol. 2009; 88(1):41-63. PMC: 2728466. DOI: 10.1016/j.pneurobio.2009.02.001. View

5.
Prusiner S, Scott M, DeArmond S, Cohen F . Prion protein biology. Cell. 1998; 93(3):337-48. DOI: 10.1016/s0092-8674(00)81163-0. View